Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,46 USD | +2,10% | +4,29% | -0,68% |
13/03 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 | |
13/03 | Spero Therapeutics, Inc. rapporteert winstresultaten voor het vierde kwartaal eindigend op 31 december 2023 | CI |
Omzet 2024 * | 48,23 mln. 45,11 mln. | Omzet 2025 * | 47,83 mln. 44,74 mln. | Marktkapitalisatie | 77,07 mln. 72,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -53 mln. -49,57 mln. | Nettowinst (verlies) 2025 * | -62 mln. -57,99 mln. | EV/omzet 2024 * | 1,6 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 1,61 x |
K/w-verhouding 2024 * |
-1,53
x | K/w-verhouding 2025 * |
-1,5
x | Werknemers | 46 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 79,63% |
Recentste transcriptie over Spero Therapeutics, Inc.
1 dag | +2,10% | ||
1 week | +4,29% | ||
Lopende maand | -15,12% | ||
1 maand | -15,61% | ||
3 maanden | -7,01% | ||
6 maanden | +46,00% | ||
Lopend jaar | -0,68% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Satyavrat Shukla
CEO | Chief Executive Officer | 52 | 04-01-21 |
Ankit Mahadevia
FOU | Founder | 43 | 01-04-13 |
Esther Rajavelu
DFI | Director of Finance/CFO | 46 | 06/11 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Frank Thomas
BRD | Director/Board Member | 54 | 01-07-17 |
John Pottage
BRD | Director/Board Member | 71 | 14-08-18 |
Scott Jackson
BRD | Director/Board Member | 60 | 16-04-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,46 | +2,10% | 165 357 |
25-04-24 | 1,43 | +0,70% | 175 454 |
24-04-24 | 1,42 | -1,05% | 110 042 |
23-04-24 | 1,435 | +2,14% | 123 862 |
22-04-24 | 1,405 | +0,36% | 295 578 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,68% | 77,07 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,37% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-14,85% | 15,52 mld. | |
+3,21% | 13,86 mld. | |
+33,54% | 12,04 mld. |